Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Baricitinib is effective and safe for treating alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Cancer treatments often cause skin, nail, and hair problems.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

SM04755 may be an effective topical treatment for psoriasis.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.